VCF-30071-76503
4 vaccinations
7 coded responses
25 check-ins
7 free-text entries
3 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 234 / VA
- Registered
- 2021-03-26
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-24
Dose 1 — Moderna
-
2021-03-26
Registered in v-safe
- 2021-03-26
- 2021-03-28
- 2021-03-30
- 2021-03-31
- 2021-04-07
-
2021-04-14
Survey response — day 21, dose 1MedDRA: Pityriasis rosea — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Pityriasis Rosea - on opposite arm of vaccinationMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-14
Report sent to call center — day 21, dose 1Get care from a doctor or other healthcare professional1 call case(s)
-
2021-04-21
Dose 2 — Moderna
- 2021-04-21
-
2021-04-22
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-04-23
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Fever · Chills, Fatigue or tiredness · Be unable to workAdult check-in
-
2021-04-24
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Headache, Muscle or body achesAdult check-in
-
2021-04-25
Survey response — days 1–6 daily, dose 2MedDRA: Pityriasis rosea — Feeling: Good · Site: Pain, RednessFree text: pityriasis rosea - has continued after first shotMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-26
Health check-in — days 1–6 daily, dose 2Feeling: Good · Rash, not including the immediate area around the injection siteAdult check-in
-
2021-04-27
Survey response — days 1–6 daily, dose 2MedDRA: Pityriasis rosea — Feeling: Good · Rash, not including the immediate area around the injection siteFree text: pityriasis rosea - not resolved yetMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-30
Survey response — day 7, dose 2MedDRA: Pityriasis rosea — Feeling: GoodFree text: pityriasis roseaMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-05-08
- 2021-05-12
- 2021-05-19
-
2021-05-28
Survey response — day 35, dose 2MedDRA: Cough, Upper-airway cough syndrome — Feeling: FairFree text: Cough, post nasal dripMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-06-04
- 2021-07-21
- 2021-10-20
-
2021-11-20
Dose 3 — Moderna
- 2022-02-19
-
2022-05-21
Survey response — 6 months, dose 3MedDRA: COVID-19 — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Covid-19- April 28thMedDRA releases: 2024-11 · check-in free text available
-
2022-05-21
Report sent to call center — 6 months, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · 1 call case(s)
-
2022-05-23
Call successfulParticipant prefers to complete VAERS report online
-
2022-05-23
Call successfulParticipant prefers to complete VAERS report online
-
2022-09-26
Dose 4 — ModernaCo-administered: Flu
-
2022-11-20
Survey response — 12 months, dose 3MedDRA: COVID-19, Delivery — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Developed Gestational Diabetes during pregnancy, immediately following covid diagnosis in April. I gave birth in August.MedDRA releases: 2024-11 · check-in free text available
-
2022-11-20
Report sent to call center — 12 months, dose 3Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-11-21
- 2022-12-28
- 2023-03-27
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-24 | Moderna | |
| 2 | 2021-04-21 | Moderna | |
| 3 | 2021-11-20 | Moderna | No |
| 4 | 2022-09-26 | Moderna | Flu |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-04-14 | Successful 2022-05-23 |
Participant prefers to complete VAERS report online |
| 2022-05-21 | Successful 2022-05-23 |
Participant prefers to complete VAERS report online |
| 2022-11-20 | Unsuccessful |
Free text
Release 7 — day 21, dose 1
Symptoms: Pityriasis Rosea - on opposite arm of vaccination
Release 7 — days 1–6 daily, dose 2
Systemic reaction (other): pityriasis rosea - has continued after first shot
Release 8 — days 1–6 daily, dose 2
Systemic reaction (other): pityriasis rosea - not resolved yet
Release 8 — day 7, dose 2
Systemic reaction (other): pityriasis rosea
Release 8 — day 35, dose 2
Symptoms: Cough, post nasal drip
Release 11 — 6 months, dose 3
Symptoms: Covid-19- April 28th
Release 12 — 12 months, dose 3
Symptoms: Developed Gestational Diabetes during pregnancy, immediately following covid diagnosis in April. I gave birth in August.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | ✓ | ✓ | ✓ |
| SD | COVID-19 | · | · | ✓ |
| SD | Delivery | · | · | ✓ |
| SD | Pityriasis rosea | ✓ | ✓ | ✓ |
| SD | Upper-airway cough syndrome | ✓ | ✓ | ✓ |
| SRO | Pityriasis rosea | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release